These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma]. Liang JW, Zhao P, Zhou ZX, Tian YT, Zhao DB, Wang CF. Zhonghua Wai Ke Za Zhi; 2009 May 01; 47(9):677-80. PubMed ID: 19615237 [Abstract] [Full Text] [Related]
6. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Kawai M, Tani M, Kobayashi Y, Tsuji T, Tabuse K, Horiuchi T, Oka M, Yamaguchi K, Sakata Y, Shimomura T, Yamaue H. Am J Surg; 2010 Apr 01; 199(4):447-52. PubMed ID: 19596119 [Abstract] [Full Text] [Related]
7. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Yoshida T, Matsumoto T, Sasaki A, Morii Y, Aramaki M, Kitano S. Arch Surg; 2002 Jan 01; 137(1):69-73. PubMed ID: 11772220 [Abstract] [Full Text] [Related]
10. Para-aortic lymph node metastasis in carcinoma of the distal bile duct. Yoshida T, Aramaki M, Bandoh T, Kawano K, Sasaki A, Matsumoto T, Morii Y, Kitano S. Hepatogastroenterology; 1998 Jan 01; 45(24):2388-91. PubMed ID: 9951929 [Abstract] [Full Text] [Related]
11. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute. Suzuki M, Unno M, Oikawa M, Endo K, Katayose Y, Matsuno S. Hepatogastroenterology; 2000 Jan 01; 47(33):650-7. PubMed ID: 10919005 [Abstract] [Full Text] [Related]
13. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. J Surg Oncol; 2007 Mar 01; 95(3):207-12. PubMed ID: 17278119 [Abstract] [Full Text] [Related]
14. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up. Bahra M, Jacob D, Langrehr JM, Neumann UP, Neuhaus P. J Hepatobiliary Pancreat Surg; 2008 Mar 01; 15(5):501-7. PubMed ID: 18836804 [Abstract] [Full Text] [Related]
15. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi-center collaborating study of Japan and Korea. Hayashi H, Jang JY, Kim KS, Choi JS, Takahara T, Choi SH, Hirano S, Yu HC, Uemura S, Unno M. J Hepatobiliary Pancreat Sci; 2020 Jun 01; 27(6):289-298. PubMed ID: 32048467 [Abstract] [Full Text] [Related]
16. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma. Akita M, Ajiki T, Ueno K, Tsugawa D, Tanaka M, Kido M, Toyama H, Fukumoto T. Hepatobiliary Pancreat Dis Int; 2020 Apr 01; 19(2):147-152. PubMed ID: 32037277 [Abstract] [Full Text] [Related]
17. P16 hypermethylation predicts surgical outcome following curative resection of mid/distal bile duct cancer. Park JS, Park YN, Lee KY, Kim JK, Yoon DS. Ann Surg Oncol; 2013 Aug 01; 20(8):2511-7. PubMed ID: 23478949 [Abstract] [Full Text] [Related]
20. Carcinoma of the gallbladder: an appraisal of surgical resection. Chijiiwa K, Tanaka M. Surgery; 1994 Jun 01; 115(6):751-6. PubMed ID: 7910985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]